Adage Capital Partners GP, L.L.C. holds a diversified book of 954 stocks worth $64.8B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Takeda Pharmaceutic-SP ADR and trimmed Nvidia Corp. Their largest long position is Nvidia Corp at 6% of the equity book. They also disclosed $48.2M in put options (a bearish bet), shown separately below and excluded from the equity book. Cloning the disclosed picks since 2013 would be +371% (+12.9%/yr). That is a simulation of the disclosed long book, not audited returns.
The reported book (valued from quarter-end) returned +382.3%, a 11.1-point gap that is the cost of the ~45-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Adage Capital Partners GP, L.L.C.'s disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~45 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
99% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Adage Capital Partners GP, L.L.C.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 80 / 80 | $2.9T |
| FMR LLC | 80 / 80 | $967.6B |
| JPMORGAN CHASE & CO | 80 / 80 | $633.7B |
| MORGAN STANLEY | 80 / 80 | $631.5B |
| BANK OF AMERICA CORP /DE/ | 80 / 80 | $381.8B |
| GOLDMAN SACHS GROUP INC | 80 / 80 | $285.0B |
| Bank of New York Mellon Corp | 80 / 80 | $254.7B |
| Legal & General Group Plc | 80 / 80 | $239.9B |
Ranked by how many of Adage Capital Partners GP, L.L.C.'s top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Nvidia Corporation COM | $3.9B | 22.10M | 5.9% | ▼−0.7% Reduced · −159K sh | |
| 2 | Apple Inc COM | $3.3B | 13.05M | 5.1% | ▼−1.4% Reduced · −180K sh | |
| 3 | Microsoft Corp COM | $2.4B | 6.58M | 3.8% | ▼−0.8% Reduced · −52K sh | |
| 4 | Amazon Com Inc COM | $1.9B | 9.16M | 2.9% | ▲+1.0% Added · +92K sh | |
| 5 | Alphabet Inc CAP STK CL A | $1.5B | 5.22M | 2.3% | ▼−0.7% Reduced · −38K sh | |
| 6 | Broadcom Inc COM | $1.3B | 4.11M | 2.0% | ▼−2.6% Reduced · −110K sh | |
| 7 | Meta Platforms Inc CL A | $1.2B | 2.06M | 1.8% | ▲+2.1% Added · +43K sh | |
| 8 | Alphabet Inc CAP STK CL C | $1.2B | 4.10M | 1.8% | ▼−1.8% Reduced · −75K sh | |
| 9 | Tesla Inc COM | $897.6M | 2.41M | 1.4% | ▼−2.4% Reduced · −58K sh | |
| 10 | Eli Lilly & Co COM | $880.1M | 956.8K | 1.4% | ▲+15% Added · +125K sh | |
| 11 | Berkshire Hathaway Inc Del CL B NEW | $804.0M | 1.68M | 1.2% | ▲+2.1% Added · +34K sh | |
| 12 | ConocoPhillips COM | $794.5M | 6.02M | 1.2% | ▼−14% Reduced · −1.0M sh | |
| 13 | JPMorgan Chase & Co COM | $710.5M | 2.42M | 1.1% | ▼−0.5% Reduced · −13K sh | |
| 14 | Johnson & Johnson COM | $602.1M | 2.46M | 0.9% | ▲+11% Added · +252K sh | |
| 15 | Revolution Medicines Inc COM | $532.5M | 5.48M | 0.8% | ▲+148% Added · +3.3M sh | |
| 16 | Chevron Corporation COM | $517.4M | 2.50M | 0.8% | ▲+40% Added · +721K sh | |
| 17 | Walmart Inc COM | $455.1M | 3.66M | 0.7% | ▼−5.5% Reduced · −211K sh | |
| 18 | Visa Inc COM CL A | $450.0M | 1.49M | 0.7% | ▼−1.2% Reduced · −18K sh | |
| 19 | Procter & Gamble Co COM | $406.9M | 2.82M | 0.6% | ▼−0.2% Reduced · −5K sh | |
| 20 | Costco Wholesale Corporation COM | $396.3M | 397.7K | 0.6% | ▲+2.1% Added · +8K sh | |
| 21 | Exxon Mobil Corp COM | $376.5M | 2.22M | 0.6% | ▼−17% Reduced · −443K sh | |
| 22 | Micron Technology Inc COM | $373.5M | 1.11M | 0.6% | ▼−0.5% Reduced · −5K sh | |
| 23 | Royalty Pharma PLC SHS CLASS A | $358.8M | 7.48M | 0.6% | ▼−36% Reduced · −4.3M sh | |
| 24 | Mastercard Incorporated CL A | $356.6M | 713.6K | 0.6% | ▼−2.3% Reduced · −17K sh | |
| 25 | Centessa Pharmaceuticals PLC SPONSORED ADS | $354.5M | 8.93M | 0.5% | ▼−21% Reduced · −2.4M sh | |
| 26 | Roivant Sciences Ltd SHS | $354.4M | 12.79M | 0.5% | ▲+20% Added · +2.1M sh | |
| 27 | Netflix Inc. COM | $349.3M | 3.63M | 0.5% | ▼−10.0% Reduced · −403K sh | |
| 28 | Merck & Co Inc COM | $323.3M | 2.69M | 0.5% | ▼~0% Reduced · −411 sh | |
| 29 | Abbvie Inc COM | $319.8M | 1.47M | 0.5% | ▼−2.5% Reduced · −38K sh | |
| 30 | Home Depot Inc COM | $313.7M | 953.9K | 0.5% | ▼−10% Reduced · −108K sh | |
| 31 | Bank America Corp COM | $312.0M | 6.40M | 0.5% | ▼−1.6% Reduced · −106K sh | |
| 32 | Cisco Sys Inc COM | $301.4M | 3.88M | 0.5% | ▼−0.6% Reduced · −23K sh | |
| 33 | Palantir Technologies Inc CL A | $299.3M | 2.05M | 0.5% | ▼−0.9% Reduced · −18K sh | |
| 34 | Ge Aerospace COM NEW | $293.6M | 1.03M | 0.5% | ▲+17% Added · +148K sh | |
| 35 | Ovintiv Inc COM | $291.3M | 4.91M | 0.4% | ▼−10% Reduced · −555K sh | |
| 36 | CSX Corp COM | $290.9M | 7.09M | 0.4% | ▲+85% Added · +3.3M sh | |
| 37 | Boston Scientific Corp COM | $290.7M | 4.63M | 0.4% | ▲+122% Added · +2.6M sh | |
| 38 | Coca Cola Co COM | $289.2M | 3.80M | 0.4% | ▲+11% Added · +377K sh | |
| 39 | Coterra Energy Inc COM | $288.8M | 8.22M | 0.4% | ▲+649% Added · +7.1M sh | |
| 40 | Oracle Corp COM | $282.3M | 1.92M | 0.4% | ▲+2.6% Added · +49K sh | |
| 41 | Caterpillar Inc COM | $274.0M | 386.8K | 0.4% | ▲+0.6% Added · +2K sh | |
| 42 | RTX Corporation COM | $272.5M | 1.41M | 0.4% | ▲+24% Added · +270K sh | |
| 43 | Advanced Micro Devices Inc COM | $269.7M | 1.33M | 0.4% | ▼−4.3% Reduced · −59K sh | |
| 44 | Thermo Fisher Scientific Inc COM | $268.3M | 545.8K | 0.4% | ▼−3.3% Reduced · −18K sh | |
| 45 | Tango Therapeutics Inc COM | $268.0M | 12.81M | 0.4% | ▲+21% Added · +2.2M sh | |
| 46 | Praxis Precision Medicines I COM NEW | $262.8M | 815.7K | 0.4% | ▼−15% Reduced · −150K sh | |
| 47 | Unitedhealth Group Inc COM | $258.8M | 956.5K | 0.4% | ▲+11% Added · +92K sh | |
| 48 | Lam Research Corp COM NEW | $247.4M | 1.16M | 0.4% | ▼−10% Reduced · −134K sh | |
| 49 | Norfolk Southn Corp COM | $245.1M | 854.0K | 0.4% | ▲+7.0% Added · +56K sh | |
| 50 | Viper Energy Inc CL A | $235.2M | 5.00M | 0.4% | ▼−12% Reduced · −707K sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1165408/holdings"
Use Arkolith to show ADAGE CAPITAL PARTNERS GP, L.L.C.'s latest holdings, largest changes, and filing provenance.
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| PUT · bearish | UNITEDHEALTH GROUP INCUNH | $32.5M | 120K |
| PUT · bearish | BOSTON SCIENTIFIC CORPBSX | $15.7M | 250K |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 956 | $64.8B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 905 | $66.1B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 872 | $63.1B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 843 | $59.3B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 837 | $54.0B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 869 | $57.2B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 864 | $56.6B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 860 | $54.0B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 864 | $53.0B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 842 | $48.3B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 859 | $44.1B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 864 | $46.0B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 913 | $44.6B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 973 | $41.8B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 1,047 | $40.3B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 1,075 | $43.6B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 1,080 | $52.7B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 1,018 | $55.5B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 1,015 | $50.8B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 1,010 | $51.1B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 951 | $49.0B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 801 | $45.9B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 16, 2020 | 748 | $39.9B | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 14, 2020 | 724 | $39.1B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.